Advanced imaging in acute stroke management-Part II: Magnetic resonance imaging

Neurology India

Volumn 57, Issue 5, 2009, Pages 550-558

  Saini, Monica ^a   Butcher, Ken ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diffusion weighted imaging; Hemorrhagic stroke; Ischemic stroke; Magnetic resonance imaging; Penumbra; Perfusion weighted imaging.

Indexed keywords

DESMOTEPLASE; FIBRINOLYTIC AGENT; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; BRAIN HEMORRHAGE; BRAIN PERFUSION; CEREBRAL ARTERY DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DRUG DOSE ESCALATION; FIBRINOLYTIC THERAPY; HUMAN; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; STROKE;

BLOOD VESSELS; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; STROKE; TIME FACTORS;

EID: 72849127359     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.57792     Document Type: Review

References (71)

1. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2 weighted and magnetic susceptibility enhanced MR imaging in cats. AJNR 1990;11:423-429
2. Poustchi-Amin M, Mirowitz SA, Brown JJ, McKinstry RJ, Li T. Principles and Applications of Echo-planar Imaging: A Review for the General Radiologist. Radiographics 2001;21:767-779
3. Desmond PM, Lovell AC, Rawlinson AA, Parsons MW, Barber PA, Yang Q, et al., Tress BM. The value of apparent diffusion coefficient maps in early cerebral ischemia. AJNR Am J Neuroradiol 2001;22:1260-1267
4. Hrabe J, Kaur G, Guilfoyle DN. Principles and limitations of NMR diffusion measurements. J Med Phys 2007;32:34-42.
5. Thulborn KR, Gindin TS, Davis D, Erb P. Comprehensive MRI protocol for stroke management: Tissue sodium concentration as a measure of tissue viability in a non-human primate model and clinical studies. Radiology 1999;139:26-34.
6. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Mag Res Imag 2005;22:710-717 (Pubitemid 41741235)
7. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: Assumptions, limitations, and potential implications for clinical use. Stroke 2002;33:1146-1151
8. Wu O, ∅stergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164-174
9. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153-1159
10. Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial Spin-Labeling in Routine Clinical Practice, Part 1: Technique and Artifacts. AJNR 2008;29:1228-1234
11. Lu H, Donahue MJ, van Zijl PC. Detrimental effects of BOLD signal in arterial spin labeling fMRI at high field strength. Magn Reson Med 2006;56:546-552
12. Hilfiker PR, Herfkens RJ, Heiss SG, Alley MT, Fleischmann D, Pelc NJ. Partial fat-saturated contrast enhanced three-dimensional MR angiography compared with nonfat-saturated and conventional fat saturated MR angiography. Radiology 2000;216:298-303.
13. Özsarlak Ö, Parizel PM, Van Goethem JW. Low-dose gadolinium enhanced 3D time-of-flight MR angiography of the intracranial vessels using PAT optimized phased array 8-channel head coil. Eur Radiol 2004;14:2067-2071
14. Dumoulin CL, Souza SP, Walker MF, Wagle W. Three-dimensional phase contrast angiography. Magn Reson Med 1989;9:139-149
15. Marchal G, Michiels J, Bosmans H, Van Hecke P. Contrast enhanced MRA of the brain. J Comput Assist Tomogr 1992;16:25-29
16. Sohn CH, Sevick RJ, Frayne R. Contrast-enhanced MR angiography of the intracranial circulation. Magn Reson Imaging Clin N Am 2003;11:599-614.
17. Debrey SM, Yu H, Lynch JK, Lövblad KO, Wright VL, Janket SJ, et al. Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: A systematic review and meta-analysis. Stroke 2008;39:2237-2248
18. Wright VL, Olan W, Dick B, Yu H, Alberts-Grill N, Latour LL, et al. Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease. Neurology 2005;65:27-32.
19. Desmond PM, Lovell AC, Rawlinson AA, Parsons MW, Barber PA, Yang Q, et al. The value of apparent diffusion coefficient maps in early cerebral ischemia. AJNR Am J Neuroradiol 2001;22:1260-1267
20. Loh PS, Butcher KS, Parsons MW, MacGregor L, Desmond PM, Tress BM, et al. Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. Stroke 2005;36:2626-2631
21. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000;47:462-469
22. Kidwell CS, Alger JR, Saver JL. Beyond Mismatch: Evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729-2735
23. Röther J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke at 6 hours. Stroke 2002;33:2438-2445
24. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ. Diffusion- and perfusion-weighted MRI: The DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-1597
25. Kane I, Carpenter T, Chappell F, Rivers C, Armitage P, Sandercock P, et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: Effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007;38:3158-3164
26. Butcher KS, Parsons MW, Davis S, Donnan G. PWI/DWI mismatch: Better definition required. Stroke 2003;34:e215-6.
27. Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153-1159
28. Heiss WD, Sobesky J. Comparison of PET and DW/PW-MRI in Acute Ischemic Stroke. Keio J Med 2008;57:125-131
29. Sobesky J, Zaro Weber O, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005;36:980-985
30. Warach S. Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI. Ann Neurol 2002;51:11-13
31. Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318-1328
32. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002;51:28-37.
33. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-1231
34. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
35. Marks MP, Olivot JM, Kemp S, Lansberg MG, Bammer R, Wechsler LR, et al. Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: Correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Radiology 2008;249:614-623
36. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebocontrolled randomised trial. Lancet Neurol 2008;7:299-309.
37. Christenson S, Parsons M, DE Silva D. Optimal mismatch definitions for detecting treatment response in acute stroke. Cerebrovasc Dis 2008;25:1-192.
38. Dávalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, et al. The clinical-DWI mismatch: A new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004;62:2187-2192
39. Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, et al.Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005;36:1700-1704
40. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, et al. Imaging of the brain in acute ischaemic stroke: Comparison of computed tomography and magnetic resonance diffusionweighted imaging. J Neurol Neurosurg Psychiatry 2005;76:1528-1533
41. Butcher K, Parsons M, Allport L, Lee SB, Barber PA, Tress B, et al. Rapid assessment of perfusion-diffusion mismatch. Stroke 2008;39:75-81.
42. Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, et al. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke 2008;39:2491-2496
43. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, et al. Risk for Symptomatic Intracerebral Hemorrhage after Thrombolysis Assessed by Diffusion-Weighted Magnetic Resonance Imaging. Ann Neurol 2008;63:52-60.
44. Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, et al. Two tales: Hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke 2007;38:313-318
45. Tong DC, Adami A, Moseley ME, Marks MP. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000;31:2378-2384
46. Selim M, Fink JN, Kumar S, Caplan LR, Horkan C, Chen Y, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: Prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002;33:2047-2052
47. Hayman L, Taber K, Ford J, Bryan R. Mechanisms of MR signal alteration by acute intracerebral blood: Old concepts and new theories. AJNR Am J Neuroradiol 1991;12:899-907.
48. Zamani AA. Imaging of intracranial hemorrhage. In: Rumbaugh CL, Wang A, Tsai FY, editors. Cerebrovascular disease imaging and interventional treatment options. New York: Igaku-Shoin; 1995. p. 232-247
49. Linfante I, Llinas RH, Caplan LR, Warach S. MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke 1999;30:2263-2267
50. Butcher KS, Baird T, MacGregor L, Desmond P, Tress B, Davis S. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 2004;35:1879-1885
51. Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 1996;27:2321-2324
52. Lin DD, Filippi CG, Steever AB, Zimmerman RD. Detection of intracranial hemorrhage: Comparison between gradient-echo images and b(0) images obtained from diffusion-weighted echo-planar sequences. AJNR Am J Neuroradiol 2001;22:1275-1281
53. Hardy PA, Kucharczyk W, Henkelman RM. Cause of signal loss in MR images of old hemorrhagic lesions. Radiology 1990;174:549-555
54. Patel R, Edelman R, Warach S. Detection of hyperacute primary intraparenchymal hemorrhge by magnetic resonance imaging. Stroke 1996;27:2321-2324
55. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823-1830
56. Greenberg S, Finklestein S, Schaefer P. Petechial hemorrhages accompanying lobar hemorrhage: Detection by gradient-echo MRI. Neurology 1996;46:1751-1754
57. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung HP. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: Evidence of microangiopathy-related microbleeds. AJNR 1999;20:637-642
58. Roob G, Lechner A, Schmidt R, Flooh E, Hartung HP, Fazekas F. Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage. Stroke 2000;31:2665-2669
59. Roob G, Kleinert R, Seifert T, Lechner A, Kapeller P, Kleinert G, et al. Indications of cerebral micro-hemorrhage in MRI. Comparative histological findings and possible clinical significance. Nervenarzt 1999;70:1082-1087
60. Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, et al. Cerebral microbleeds: Prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004;35:1831-1835
61. Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52:991-994
62. Chalela JA, Kang DW, Warach S. Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging 2004;14:54-57
63. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: An emerging application. Stroke 2002;33:95-98
64. Nighoghossian N, Hermier M, Adeleine P, Blanc-Lasserre K, Derex L, Honnorat J, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: A gradient-echo T2*-weighted brain MRI study. Stroke 2002;33:735-742
65. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, et al. Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled analysis of T2 weighted magnetic resonance imaging data from 570 patients. Stroke 2007;38:2738-2744
66. Lee SH, Bae HJ, Kwon SJ, Kim H, Kim YH, Yoon BW, et al. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004;62:72-76
67. Ibaraki M, Shimosegawa E, Miura S, Takahashi K, Ito H, Kanno I, et al. PET measurements of CBF, OEF, CMRO2 without arterial sampling in hyperacute ischemic stroke: Method and error analysis. Ann Nuc Med 2004;18:35-44.
68. Mahagne MH, Darcourt J, Migneco O, Fournier JP, Thiercelin D, Ducoeur S, et al. Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery. Cerebrovasc Dis 2000;10:364-373
69. Alexandrov AV, Grotta JC, Davis SM, Lassen NA. Brain SPECT and thrombolysis in acute ischemic stroke: Time for a clinical trial. J NucIMed 1996;37:1259-1262
70. Giubilei F, Lenzi GL, Di Piero V, Pozzilli C, Pantano P, Bastianello S, et al. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke 1990;21:895-900.
71. Ueda T, Sakaki S, Yuh WTC, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cerebr Blood Flow Metab 1999;10:99-108.